SNDY Is Looking Pretty Again, Up To 100% Upside To The 50 DMA
Good Evening!
Solos Endoscopy, Inc. (OTCPINK: SNDY)
SNDY has been very generous to traders this year and I’ve looked carefully at the play and believe that it is about to issue another round of gain potential -- the first big rally for May and you are getting a chance to move before everyone else does.
This is how things have panned out for the company over the last few months. In February SNDY delivered one of its biggest one-day performances, rising from an open of .09 to a high of .15 for gains of up to 66%.
February saw sporadic breakouts but the next biggest delivery came on March 1 when SNDY opened at .10 and rallied to a high of .13 for gains of up to 30%. The rallies from then on were smaller but April 18 saw a major spike; SNDY rocketed from an open of .04 to a .06 high. This delivered one-day gains of up to 50%.
Now it’s May and I believe there is potential for much larger spikes. The bullish near term outlook is based partly on the fact that SNDY has undergone considerable consolidation over the last few weeks. So far May has produced none of the patterned breakouts delivered in other months which make the current chart a good gauge for urgent entry.
Basically, you are looking at play positioned from bottom – RSI is 34 on the daily chart and daily volatility levels are looking skyward.
The dirt cheap entry of around .02 should be a major catalyst for action right now. This is especially so when you consider that the 4-week high of .06 suggests upside opportunity of around 200%.
In other words, the potential upside currently offered by SNDY is greater than the aforementioned breakouts combined!
Here’s a link to the chart: http://www.barchart.com/interactive_charts/stocks/SNDY
About
SNDY (Solos Endoscopy, Inc.) is a healthcare technology company whose mission is to develop and market breakthrough technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment and management of medical conditions. Backed by technical support, Solos' sales team can help make the right buying decisions for the hospital, surgery center, or physician office.
US Medical Device Market On Track For $133 Billion In 2016
The United States remains the largest medical device market in the world with a market size of around $110 billion, and it is expected to reach $133 billion by 2016.
The U.S. market value represented about 38 percent of the global medical device market in 2012. U.S. exports of medical devices in key product categories identified by the Department of Commerce (DOC) exceeded $44 billion in 2012, a more than 7 percent increase from the previous year.
News Development
Solos Endoscopy Fulfills Backorders for MammoView(R) Ductoscopy Instruments
SNDY has resumed sales of its MammoView® Ductoscopy Instruments as a result of its ability to fulfil all of its backorders, which were due to production issues experienced from one of its component manufacturers. The component manufacturer has resolved its production issue and has resumed its deliveries, on a timely basis, to Solos and is confident that it will not experience this issue in the future.
"The production issues have been successfully addressed and I'm confident in the uninterrupted sale and production of the MammoView® product line going forward," stated Robert Segersten, CEO.
Solos Endoscopy, Inc. FDA Establishment Registration & Device Listing Renewed for 2016
SNDY has also renewed the Establishment Registration & Device Listing of its endoscopic instruments with the U.S. Food and Drug Administration (FDA).
Solos Endoscopy instruments are registered and approved with the FDA; the FDA approval also covers the entire MammoView® instrument line. The company markets over 200 items to the endoscopic market and is continuing the development of products that will enhance the ability of medical professionals to perform minimally invasive surgical techniques.
To learn more about SNDY please visit their website: http://www.solosendoscopy.com/
SNDY is primed again for another round of gain potential; you’ve seen it play out in the charts so make your move ASAP.
Jeff "The Mirkinator" Mirkin
IMPORTANT DISCLAIMER
This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by Stellar Media Group, LLC. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” or “Stellar Media” refers to Stellar Media Group, LLC. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website.
We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. Stellar Media’s business model is to receive financial compensation to promote public companies. We have been compensated $25k cash via bank wire by a third party, ACN, LLC, to conduct investor relations advertising and marketing for SNDY. This compensation is a major conflict of interest in our ability to be unbiased regarding . Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forword looking statements, which are not guaranteed to materialize due to a variety of factors.
We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, Stellar Media often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice. See full disclaimer at www.damngoodpennypicks.com/disclaimer.php.
